<!DOCTYPE html>
<html>
	<head>
		<meta charset="UTF-8" />
		<title>How antipsychotics work in schizophrenia: A primer on mechanisms</title>
		<link rel="stylesheet" href="../styles.css">
	</head>
	<body>
		<nav>
		<p><a href="../index.html">< Back to Home</a></p>
	</nav>
		<h1>How antipsychotics work in schizophrenia: A primer on mechanisms</h1>
		<h4>Cambridge Core 2024 Review</h4>
		<h3>Key Terms</h3>
		<ul>
			<li><strong>schizophrenia</strong> - a serious, chronic mental illness that involves hallucinations, delusions, and disorganized thinking and behavior<sup><a href="https://www.mayoclinic.org/diseases-conditions/schizophrenia/symptoms-causes/syc-20354443">1</a></sup></li>

			<li class="indent-list">positive symptoms of schizophrenia consist of "hallucinations, delusions, disorganized speech/behavior" (Meyer 2024)</li>
			<li class="indent-list">negative symptoms of schizophrenia consist of apathy<sup><a href="https://my.clevelandclinic.org/health/symptoms/24824-apathy">3</a></sup> (lack of feeling or interest) and decreased expressiveness</li>
			<li class="indent-list">cognitive deficits caused by  schizophrenia consist of impaired "working memory, processing speed, and executive function" (Meyer 2024)</li>

			<li><strong>psychosis</strong> - a combination of symptoms that distance a person from reality<sup><a href="https://my.clevelandclinic.org/health/symptoms/23012-psychosis">2</a></sup></li>
		</ul>

		<h3>Summary</h3>
		<p>Since each schizophrenia patient presents a unique combination of symptoms, it is difficult to find one one-size-fits-all schizophrenia medication.</p>
		<p>Most antipsychotic medication approved before 2024 use dopamine D2 receptor antagonism. The dopamine D2 receptor is a G protein-coupled receptor in the brain that regulate dopamine levels<sup><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4108583/">4</a></sup>. In other words, these antipsychotics work by binding onto dopamine D2 receptors, preventing dopamine from binding.</p>

		<p>Clozapine is a newer drug that works differently and succeeds at treating the 1/3 of patients that don't respond to dopamine D2 receptor medications. Unfortunately, its exact mechanisms are currently unknown.</p>

		<p>Schizophrenia patients who are <i>not treatment resistant</i> respond well to medications that reduce dopamine production in the brain (e.g. dopamine D2 receptor medications). This strategy reduces positive symptoms.</p>

		<h4>Sources:</h4>
		<ol>
			<li>https://www.mayoclinic.org/diseases-conditions/schizophrenia/symptoms-causes/syc-20354443</li>
			<li>https://my.clevelandclinic.org/health/symptoms/23012-psychosis</li>
			<li>https://my.clevelandclinic.org/health/symptoms/24824-apathy</li>
			<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC4108583/</li>
		</ol>
	</body>
</html>